Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) EBT Margin (2023 - 2025)

Upstream Bio has reported EBT Margin over the past 3 years, most recently at 6364.22% for Q4 2025.

  • Quarterly results put EBT Margin at 6364.22% for Q4 2025, down 289897.0% from a year ago — trailing twelve months through Dec 2025 was 5025.51% (down 225585.0% YoY), and the annual figure for FY2025 was 5025.51%, down 225585.0%.
  • EBT Margin for Q4 2025 was 6364.22% at Upstream Bio, down from 4938.36% in the prior quarter.
  • Over the last five years, EBT Margin for UPB hit a ceiling of 1265.54% in Q3 2023 and a floor of 6364.22% in Q4 2025.
  • Median EBT Margin over the past 3 years was 3170.18% (2024), compared with a mean of 3561.54%.
  • Biggest five-year swings in EBT Margin: crashed -61836bps in 2024 and later plummeted -289897bps in 2025.
  • Upstream Bio's EBT Margin stood at 2846.89% in 2023, then dropped by -22bps to 3465.25% in 2024, then tumbled by -84bps to 6364.22% in 2025.
  • The last three reported values for EBT Margin were 6364.22% (Q4 2025), 4938.36% (Q3 2025), and 4259.98% (Q2 2025) per Business Quant data.